Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium

Introduction: Vaccination of hamsters with Schistosoma mansoni adjuvant-free recombinant cathepsin B1 (SmCB1) and L3 (SmCL3) have been shown to elicit highly significant (P < 0.005) protection against challenge Schistosoma haematobium that was not very superior to that achieved by the cysteine pe...

Full description

Bibliographic Details
Main Authors: Nada Abdel Aziz, Hatem Tallima, Marwa Abou El Dahab, Rashika El Ridi
Format: Article
Language:English
Published: Pasteur Institute of Iran 2019-12-01
Series:Vaccine Research
Subjects:
Online Access:http://vacres.pasteur.ac.ir/article-1-164-en.html
id doaj-47eff60fb4864b699cbade5fc905ae04
record_format Article
spelling doaj-47eff60fb4864b699cbade5fc905ae042020-11-25T03:48:37ZengPasteur Institute of IranVaccine Research2383-28192423-49232019-12-016218Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobiumNada Abdel Aziz0Hatem Tallima1Marwa Abou El Dahab2Rashika El Ridi3 Faculty of SCience, Cairo University Faculty of Science, Cairo University Faculty of Science, Ein Shams University Zoology Department, Faculty of Science, Cairo University Introduction: Vaccination of hamsters with Schistosoma mansoni adjuvant-free recombinant cathepsin B1 (SmCB1) and L3 (SmCL3) have been shown to elicit highly significant (P < 0.005) protection against challenge Schistosoma haematobium that was not very superior to that achieved by the cysteine peptidase, papain.  Sterilizing immunity might, however, be induced if hamsters were vaccinated against S. haematobium infection with a homologous cysteine peptidase, i.e., S. haematobium cathepsin L (ShCL).   Methods: Standards methods, techniques, and primers based on the published nucleotide sequence of ShCL were used to clone, amplify and express DNAs encoding the target enzyme in a bacterial expression vector.  Repeat immunization trials were performed using recombinant ShCL alone or in combination with the vaccine candidate S. mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase, in parallel with S. mansoni lecucine aminopeptidase.  Results: The results together indicated that our adjuvant-free, cysteine peptidase-based vaccine elicits highly significant (P < 0.0001) reduction in challenge worm burden and parasite egg viability.  Protection was associated with whole blood cultures release of type 1, type 2, and type 17 cytokines, and modest, yet significant (P < 0.05) humoral response to ShCL.  Conclusion: Sterilizing immunity was, however, not achieved in any trial, likely because of the preponderant role of cysteine peptidases-induced nonspecific factors in amplifying and antagonizing its protective potential.  Experiments are planned in an aim to identify these elusive factors and their exact role.http://vacres.pasteur.ac.ir/article-1-164-en.htmlschistosoma haematobiumhamsterscysteine peptidasesvaccinerecombinant proteinsantibody response
collection DOAJ
language English
format Article
sources DOAJ
author Nada Abdel Aziz
Hatem Tallima
Marwa Abou El Dahab
Rashika El Ridi
spellingShingle Nada Abdel Aziz
Hatem Tallima
Marwa Abou El Dahab
Rashika El Ridi
Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium
Vaccine Research
schistosoma haematobium
hamsters
cysteine peptidases
vaccine
recombinant proteins
antibody response
author_facet Nada Abdel Aziz
Hatem Tallima
Marwa Abou El Dahab
Rashika El Ridi
author_sort Nada Abdel Aziz
title Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium
title_short Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium
title_full Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium
title_fullStr Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium
title_full_unstemmed Immunogenicity and Protective Capacity of Schistosoma haematobium Recombinant cathepsin L Against Infection of Hamsters with S. haematobium
title_sort immunogenicity and protective capacity of schistosoma haematobium recombinant cathepsin l against infection of hamsters with s. haematobium
publisher Pasteur Institute of Iran
series Vaccine Research
issn 2383-2819
2423-4923
publishDate 2019-12-01
description Introduction: Vaccination of hamsters with Schistosoma mansoni adjuvant-free recombinant cathepsin B1 (SmCB1) and L3 (SmCL3) have been shown to elicit highly significant (P < 0.005) protection against challenge Schistosoma haematobium that was not very superior to that achieved by the cysteine peptidase, papain.  Sterilizing immunity might, however, be induced if hamsters were vaccinated against S. haematobium infection with a homologous cysteine peptidase, i.e., S. haematobium cathepsin L (ShCL).   Methods: Standards methods, techniques, and primers based on the published nucleotide sequence of ShCL were used to clone, amplify and express DNAs encoding the target enzyme in a bacterial expression vector.  Repeat immunization trials were performed using recombinant ShCL alone or in combination with the vaccine candidate S. mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase, in parallel with S. mansoni lecucine aminopeptidase.  Results: The results together indicated that our adjuvant-free, cysteine peptidase-based vaccine elicits highly significant (P < 0.0001) reduction in challenge worm burden and parasite egg viability.  Protection was associated with whole blood cultures release of type 1, type 2, and type 17 cytokines, and modest, yet significant (P < 0.05) humoral response to ShCL.  Conclusion: Sterilizing immunity was, however, not achieved in any trial, likely because of the preponderant role of cysteine peptidases-induced nonspecific factors in amplifying and antagonizing its protective potential.  Experiments are planned in an aim to identify these elusive factors and their exact role.
topic schistosoma haematobium
hamsters
cysteine peptidases
vaccine
recombinant proteins
antibody response
url http://vacres.pasteur.ac.ir/article-1-164-en.html
work_keys_str_mv AT nadaabdelaziz immunogenicityandprotectivecapacityofschistosomahaematobiumrecombinantcathepsinlagainstinfectionofhamsterswithshaematobium
AT hatemtallima immunogenicityandprotectivecapacityofschistosomahaematobiumrecombinantcathepsinlagainstinfectionofhamsterswithshaematobium
AT marwaaboueldahab immunogenicityandprotectivecapacityofschistosomahaematobiumrecombinantcathepsinlagainstinfectionofhamsterswithshaematobium
AT rashikaelridi immunogenicityandprotectivecapacityofschistosomahaematobiumrecombinantcathepsinlagainstinfectionofhamsterswithshaematobium
_version_ 1724498029211287552